Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0000930413-05-000396

Director sold 392,109 shares at an average $4.28 ($1,679,830)

From the SEC's structured data for this filing

Trades in this filing

MOORE JOHN A · Director

Table I: Non-derivative

13 lines
Date Transaction Shares Price Value Owned after D/I
2005-01-24 Sale : show line 1 in the form −10,000 $4.14 $41,400 53,000 D
2005-01-21 Sale : show line 2 in the form −25,000 $4.27 $106,743 53,000 D
2005-01-21 Sale : show line 3 in the form −25,000 $4.31 $107,633 53,000 D
2005-01-21 Sale : show line 4 in the form −32,109 $4.35 $139,674 53,000 D
2005-01-21 Sale : show line 5 in the form −50,000 $4.32 $216,000 53,000 D
2005-01-21 Sale : show line 6 in the form −125,000 $4.30 $537,500 53,000 D
2005-01-21 Sale : show line 7 in the form −25,000 $4.27 $106,750 53,000 D
2005-01-21 Sale : show line 8 in the form −40,000 $4.25 $170,000 53,000 D
Open-market sales · 392,109 sh · avg $4.28 · $1,679,830
Loading xslF345X02/c35236_ex.xml…